Network for network concept offers new insights into host-SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs
Abstract SARS-CoV-2, the causal agent of COVID-19, is primarily a pulmonary virus that can
directly or indirectly infect several organs. Despite many studies carried out during the …
directly or indirectly infect several organs. Despite many studies carried out during the …
A network biology approach to identify crucial host targets for COVID-19
The ongoing global pandemic of COVID-19, caused by SARS-CoV-2 has killed more than
5.9 million individuals out of∼ 43 million confirmed infections. At present, several parts of …
5.9 million individuals out of∼ 43 million confirmed infections. At present, several parts of …
Analyzing host-viral interactome of sars-cov-2 for identifying vulnerable host proteins during covid-19 pathogenesis
The development of therapeutic targets for COVID-19 relies on understanding the molecular
mechanism of pathogenesis. Identifying genes or proteins involved in the infection …
mechanism of pathogenesis. Identifying genes or proteins involved in the infection …
COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection
Background Epidemiological, virological and pathogenetic characteristics of SARS-CoV-2
infection are under evaluation. A better understanding of the pathophysiology associated …
infection are under evaluation. A better understanding of the pathophysiology associated …
A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Studying viral–host protein–protein interactions can facilitate the discovery of therapies for
viral infection. We use high-throughput yeast two-hybrid experiments and mass spectrometry …
viral infection. We use high-throughput yeast two-hybrid experiments and mass spectrometry …
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome
In the last months, many studies have clearly described several mechanisms of SARS-CoV-
2 infection at cell and tissue level, but the mechanisms of interaction between host and …
2 infection at cell and tissue level, but the mechanisms of interaction between host and …
Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain–human …
SARS-CoV-2 has become a pandemic causing a serious global health concern. The
absence of effective drugs for treatment of the disease has caused its rapid spread on a …
absence of effective drugs for treatment of the disease has caused its rapid spread on a …
Interactome of SARS-CoV-2 modulated host proteins with computationally predicted PPIs: insights from translational systems biology studies
KB Karunakaran, N Balakrishnan… - Frontiers in Systems …, 2022 - frontiersin.org
Accelerated efforts to identify intervention strategies for the COVID-19 pandemic caused by
SARS-CoV-2 need to be supported by deeper investigations into host invasion and …
SARS-CoV-2 need to be supported by deeper investigations into host invasion and …
CovMulNet19, integrating proteins, diseases, drugs, and symptoms: a network medicine approach to COVID-19
Introduction: We introduce in this study CovMulNet19, a comprehensive COVID-19 network
containing all available known interactions involving SARS-CoV-2 proteins, interacting …
containing all available known interactions involving SARS-CoV-2 proteins, interacting …
[HTML][HTML] A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to unprecedented social and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to unprecedented social and …
相关搜索
- host proteins sars cov
- covid 19 sars cov
- antiviral drugs host sars
- protein interactions antiviral drugs
- human genes sars cov
- pathogenic mechanisms sars cov
- lung disease sars cov
- host interactome sars cov
- protein interactions host sars
- protein interactions sars cov
- antiviral drugs sars cov
- human protein sars cov
- virus host sars cov
- molecular mechanisms sars cov